These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31939443)

  • 1. MALAT1 and BACH1 are prognostic biomarkers for triple-negative breast cancer.
    Ou X; Gao G; Bazhabayi M; Zhang K; Liu F; Xiao X
    J Cancer Res Ther; 2019; 15(7):1597-1602. PubMed ID: 31939443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Implications of MALAT1 and BACH1 Expression and Their Correlation with CTCs and Mo-MDSCs in Triple Negative Breast Cancer and Surgical Management Options.
    Elbasateeny SS; Yassin MA; Mokhtar MM; Ismail AM; Ebian HF; Hussein S; Shazly SA; Abdelwabab MM
    Int J Breast Cancer; 2022; 2022():8096764. PubMed ID: 35096427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development.
    Jin C; Yan B; Lu Q; Lin Y; Ma L
    Tumour Biol; 2016 Jun; 37(6):7383-94. PubMed ID: 26676637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer.
    Jadaliha M; Zong X; Malakar P; Ray T; Singh DK; Freier SM; Jensen T; Prasanth SG; Karni R; Ray PS; Prasanth KV
    Oncotarget; 2016 Jun; 7(26):40418-40436. PubMed ID: 27250026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer.
    Zuo Y; Li Y; Zhou Z; Ma M; Fu K
    Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of NR1D1 is associated with good prognosis in triple-negative breast cancer patients treated with chemotherapy.
    Na H; Han J; Ka NL; Lee MH; Choi YL; Shin YK; Lee MO
    Breast Cancer Res; 2019 Nov; 21(1):127. PubMed ID: 31779659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stratifying triple-negative breast cancer prognosis using 18F-FDG-PET/CT imaging.
    Yue Y; Cui X; Bose S; Audeh W; Zhang X; Fraass B
    Breast Cancer Res Treat; 2015 Oct; 153(3):607-16. PubMed ID: 26346756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of long non-coding RNAs in triple negative breast cancer: A PRISMA-compliant meta-analysis.
    Zhang S; Ma F; Xie X; Shen Y
    Medicine (Baltimore); 2020 Sep; 99(37):e21861. PubMed ID: 32925722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival.
    Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Loo LWM; Jia W; Obata Y; Yu H
    Breast Cancer Res Treat; 2018 Sep; 171(2):261-271. PubMed ID: 29845475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers.
    Yue Y; Astvatsaturyan K; Cui X; Zhang X; Fraass B; Bose S
    PLoS One; 2016; 11(3):e0149661. PubMed ID: 26930401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of HABP1 is a novel prognostic indicator in triple-negative breast cancers.
    Wang J; Song Y; Liu T; Shi Q; Zhong Z; Wei W; Huang S; Pang D
    Tumour Biol; 2015 Jun; 36(6):4793-9. PubMed ID: 25794640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism.
    Lee J; Yesilkanal AE; Wynne JP; Frankenberger C; Liu J; Yan J; Elbaz M; Rabe DC; Rustandy FD; Tiwari P; Grossman EA; Hart PC; Kang C; Sanderson SM; Andrade J; Nomura DK; Bonini MG; Locasale JW; Rosner MR
    Nature; 2019 Apr; 568(7751):254-258. PubMed ID: 30842661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of p53 expression with poor prognosis in patients with triple-negative breast invasive ductal carcinoma.
    Li JP; Zhang XM; Zhang Z; Zheng LH; Jindal S; Liu YJ
    Medicine (Baltimore); 2019 May; 98(18):e15449. PubMed ID: 31045815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases.
    Zhang Y; Dai J; McNamara KM; Bai B; Shi M; Chan MS; Liu M; Sasano H; Wang X; Li X; Liu L; Ma Y; Cao S; Xing Y; Zhao B; Song Y; Wang L
    BMC Cancer; 2015 Oct; 15():699. PubMed ID: 26472563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXO3a expression is associated with lymph node metastasis and poor disease-free survival in triple-negative breast cancer.
    Rehman A; Kim Y; Kim H; Sim J; Ahn H; Chung MS; Shin SJ; Jang K
    J Clin Pathol; 2018 Sep; 71(9):806-813. PubMed ID: 29588373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BTB and CNC homology 1 (Bach1) promotes human ovarian cancer cell metastasis by HMGA2-mediated epithelial-mesenchymal transition.
    Han W; Zhang Y; Niu C; Guo J; Li J; Wei X; Jia M; Zhi X; Yao L; Meng D
    Cancer Lett; 2019 Mar; 445():45-56. PubMed ID: 30654010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prognostic gene signature for metastasis-free survival of triple negative breast cancer patients.
    Lee U; Frankenberger C; Yun J; Bevilacqua E; Caldas C; Chin SF; Rueda OM; Reinitz J; Rosner MR
    PLoS One; 2013; 8(12):e82125. PubMed ID: 24349199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma.
    Tavares MC; Sampaio CD; Lima GE; Andrade VP; Gonçalves DG; Macedo MP; Cordeiro de Lima VC
    BMC Cancer; 2021 Aug; 21(1):901. PubMed ID: 34362334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer.
    Wu J; Cai Y; Zhao G; Li M
    J Clin Lab Anal; 2021 Jun; 35(6):e23779. PubMed ID: 33934391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.